Intellectual property issues in a clinical trial: a corporate perspective.
作者信息
Fersko R S, Connolly M J
机构信息
Tanner Propp & Fersko, New York, New York 10016.
出版信息
Qual Assur. 1992 Jun;1(3):237-48.
PMID:1344679
Abstract
摘要
相似文献
1
Intellectual property issues in a clinical trial: a corporate perspective.临床试验中的知识产权问题：企业视角
Qual Assur. 1992 Jun;1(3):237-48.
2
Research interactions between industry and academia: a corporate perspective.产业界与学术界之间的研究互动：企业视角。
Physiologist. 1996 Jun;39(3):81, 90-2.
3
Grant proposal reviewer says he would have scored proposal lower due to conflict of interest.资助提案评审人表示，由于利益冲突，他会给该提案打更低的分数。
Hum Res Rep. 2004 Dec;19(12):8.
4
FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.美国食品药品监督管理局发布临床试验利益冲突规则。美国食品药品监督管理局。
AIDS Treat News. 1998 Mar 6(No 290):8.
5
Regulating scientific research: intellectual property rights and the norms of science.规范科学研究：知识产权与科学规范
Northwest Univ Law Rev. 1999 Fall;94(1):77-152.
6
Researcher said his colleague should have revealed possible conflicts of interest.研究人员表示，他的同事本应披露可能存在的利益冲突。
Hum Res Rep. 2005 Jan;20(1):8.
7
NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.神经中枢：随着许多学术医疗中心进行自查，美国监察长办公室就国立卫生研究院对利益冲突监督不力发出警告。
Ann Neurol. 2010 Mar;67(3):A7-A10. doi: 10.1002/ana.22026.
8
Razing the tollbooths. A call for restricting patents on basic biomedical research.
Sci Am. 2003 Apr;288(4):37.
9
March-in rights under the Bayh-Dole Act: the NIH's paper tiger?《拜杜法案》下的 march-in 权利：美国国立卫生研究院的纸老虎？
Seton Hall Law Rev. 2013 Nov 1;43(4):1403-32.
10
Is academic medicine for sale?学术医学是可以买卖的吗？
N Engl J Med. 2000 Aug 17;343(7):509; author reply 510.
Zotero 插件